T-Cell Function Is Critical for Murine Cholesterol Gallstone Formation

Gastroenterology

Volumn 133, Issue 4, 2007, Pages 1304-1315

  Maurer, Kirk J ^a,b   Rao, Varada P ^a   Ge, Zhongming ^a   Rogers, Arlin B ^a   Oura, Trisha J ^a   Carey, Martin C ^b   Fox, James G ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CHOLECYSTITIS; CHOLESTEROL STONE; CONTROLLED STUDY; GENE EXPRESSION; HELICOBACTER; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LYMPHOCYTE TRANSFER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 34848881295     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.07.005     Document Type: Article

References (59)

1. Paigen B., and Carey M.C. Gallstones. In: King R.A., Rotter J.I., and Motulsky A.G. (Eds). Genetic basis of common diseases. 2nd ed. (2002), Oxford University Press, New York 298-335
2. Katsika D., Grjibovski A., Einarsson C., et al. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 41 (2005) 1138-1143
3. Carey M.C., and LaMont J.T. Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 10 (1992) 139-163
4. Carey M.C. Pathogenesis of gallstones. Recent Prog Med 83 (1992) 379-391
5. Hofmann A.F. Pathogenesis of cholesterol gallstones. J Clin Gastroenterol 10 Suppl 2 (1988) S1-S11
6. Afdhal N.H., Niu N., Gantz D., et al. Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile. Gastroenterology 104 (1993) 1515-1523
7. Levy P.F., Smith B.F., and LaMont J.T. Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 87 (1984) 270-275
8. Smith B.F. Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile. Hepatology 12 (1990) 183S-186S discussion 186S-188S
9. Yamasaki T., Chijiiwa K., and Endo M. Isolation of mucin from human hepatic bile and its induced effects on precipitation of cholesterol and calcium carbonate in vitro. Dig Dis Sci 38 (1993) 909-915
10. Harvey P.R., and Upadhya G.A. A rapid, simple high capacity cholesterol crystal growth assay. J Lipid Res 36 (1995) 2054-2058
11. Harvey P.R., Upadhya G.A., and Strasberg S.M. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 266 (1991) 13996-14003
12. Hattori Y., Tazuma S., Yamashita G., et al. Influence of cholesterol crystallization effector proteins on vesicle fusion in supersaturated model bile. J Gastroenterol Hepatol 14 (1999) 669-674
13. Maurer K.J., Ihrig M.M., Rogers A.B., et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128 (2005) 1023-1033
14. Fox J.G. The non-H pylori helicobacters: their expanding role in gastrointestinal and systemic diseases. Gut 50 (2002) 273-283
15. Maurer K.J., Rogers A.B., Ge Z., et al. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 290 (2006) G175-G182
16. Belzer C., Kusters J.G., Kuipers E.J., et al. Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 55 (2006) 1678-1679
17. Whary M.T., Morgan T.J., Dangler C.A., et al. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect Immun 66 (1998) 3142-3148
18. Fox J.G., Beck P., Dangler C.A., et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6 (2000) 536-542
19. Eaton K.A., Ringler S.R., and Danon S.J. Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect Immun 67 (1999) 4594-4602
20. Eaton K.A., Mefford M., and Thevenot T. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 166 (2001) 7456-7461
21. Wang D.Q., Paigen B., and Carey M.C. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38 (1997) 1395-1411
22. Finzi L., Barbu V., Burgel P.R., et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. Am J Pathol 169 (2006) 2031-2041
23. Rege R.V., and Prystowsky J.B. Inflammation and a thickened mucus layer in mice with cholesterol gallstones. J Surg Res 74 (1998) 81-85
24. Jennings L.J., Xu Q.W., Firth T.A., et al. Cholesterol inhibits spontaneous action potentials and calcium currents in guinea pig gallbladder smooth muscle. Am J Physiol 277 (1999) G1017-G1026
25. Koninger J., di Mola F.F., Di Sebastiano P., et al. Transforming growth factor-beta pathway is activated in cholecystolithiasis. Langenbecks Arch Surg 390 (2005) 21-28
26. Lee S.P., Carey M.C., and LaMont J.T. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 211 (1981) 1429-1431
27. Gilroy D.W. New insights into the anti-inflammatory actions of aspirin-induction of nitric oxide through the generation of epi-lipoxins. Mem Inst Oswaldo Cruz 100 Suppl 1 (2005) 49-54
28. Miquel J.F., Nunez L., Rigotti A., et al. Isolation and partial characterization of cholesterol pronucleating hydrophobic glycoproteins associated to native biliary vesicles. FEBS Lett 318 (1993) 45-49
29. Upadhya G.A., Harvey P.R., and Strasberg S.M. Effect of human biliary immunoglobulins on the nucleation of cholesterol. J Biol Chem 268 (1993) 5193-5200
30. Rhodes M., Allen A., and Lennard T.W. Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin. Gut 33 (1992) 1109-1112
31. Kim H.J., Lee S.K., Kim M.H., et al. Cyclooxygenase-2 mediates mucin secretion from epithelial cells of lipopolysaccharide-treated canine gallbladder. Dig Dis Sci 48 (2003) 726-732
32. van Erpecum K.J., Wang D.Q., Lammert F., et al. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol 35 (2001) 444-451
33. van Erpecum K.J., Wang D.Q., Moschetta A., et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 47 (2006) 32-41
34. Emoto Y., Emoto M., Miyamoto M., et al. Functionally active CD8alphabeta+ TCRgammadelta intestinal intraepithelial lymphocytes in athymic nu/nu mice. Int Immunol 16 (2004) 111-117
35. Guy-Grand D., Azogui O., Celli S., et al. Extrathymic T cell lymphopoiesis: ontogeny and contribution to gut intraepithelial lymphocytes in athymic and euthymic mice. J Exp Med 197 (2003) 333-341
36. Xiao Z.L., Andrada M.J., Biancani P., et al. Reactive oxygen species (H(2)O(2)): effects on the gallbladder muscle of guinea pigs. Am J Physiol Gastrointest Liver Physiol 282 (2002) G300-G306
37. Xiao Z.L., Rho A.K., Biancani P., et al. Effects of bile acids on the muscle functions of guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 283 (2002) G87-G94
38. Izcue A., Coombes J.L., and Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212 (2006) 256-271
39. Abayli B., Colakoglu S., Serin M., et al. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol 39 (2005) 134-137
40. Bulajic M., Maisonneuve P., Schneider-Brachert W., et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 95 (2002) 1946-1953
41. Silva C.P., Pereira-Lima J.C., Oliveira A.G., et al. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 41 (2003) 5615-5618
42. Fox J.G. Other helicobacters involved in human diseases. Acta Gastroenterol Belg 65 (2002) 24-32
43. O'Rourke J.L., Solnick J.V., Neilan B.A., et al. Description of "Candidatus Helicobacter heilmannii" based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 54 (2004) 2203-2211
44. Mathai E., Arora A., Cafferkey M., et al. The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment Pharmacol Ther 5 (1991) 653-658
45. Hanninen M.L. Sensitivity of Helicobacter pylori to different bile salts. Eur J Clin Microbiol Infect Dis 10 (1991) 515-518
46. Hilgers J., van Nie R., Ivanyi D., et al. Genetic differences in BALB/c sublines. Curr Top Microbiol Immunol 122 (1985) 19-30
47. Dewhirst F.E., Chien C.C., Paster B.J., et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65 (1999) 3287-3292
48. Singer S.M., and Nash T.E. The role of normal flora in Giardia lamblia infections in mice. J Infect Dis 181 (2000) 1510-1512
49. Sarma-Rupavtarm R.B., Ge Z., Schauer D.B., et al. Spatial distribution and stability of the eight microbial species of the altered Schaedler flora in the mouse gastrointestinal tract. Appl Environ Microbiol 70 (2004) 2791-2800
50. Kuehl C.J., Wood H.D., Marsh T.L., et al. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun 73 (2005) 6952-6961
51. Pena J.A., Rogers A.B., Ge Z., et al. Probiotic Lactobacillus spp. diminish Helicobacter hepaticus-induced inflammatory bowel disease in interleukin-10-deficient mice. Infect Immun 73 (2005) 912-920
52. Pena J.A., and Versalovic J. Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 5 (2003) 277-285
53. Bini E.J., and McGready J. Prevalence of gallbladder disease among persons with hepatitis C virus infection in the United States. Hepatology 41 (2005) 1029-1036
54. Chang T.S., Lo S.K., Shyr H.Y., et al. Hepatitis C virus infection facilitates gallstone formation. J Gastroenterol Hepatol 20 (2005) 1416-1421
55. Fraquelli M., Losco A., Visentin S., et al. Gallstone disease and related risk factors in patients with Crohn's disease: analysis of 330 consecutive cases. Arch Intern Med 161 (2001) 2201-2204
56. Hutchinson R., Tyrrell P.N., Kumar D., et al. Pathogenesis of gall stones in Crohn's disease: an alternative explanation. Gut 35 (1994) 94-97
57. Fox J.G., and Wang T.C. Inflammation, atrophy, and gastric cancer. J Clin Invest 117 (2007) 60-69
58. Reiss A.B., and Glass A.D. Atherosclerosis: immune and inflammatory aspects. J Invest Med 54 (2006) 123-131
59. Zozulinska D., and Wierusz-Wysocka B. Type 2 diabetes mellitus as inflammatory disease. Diabetes Res Clin Pract 74 (2006) S12-S16